Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1108693

	registered interest
	date	01/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on the prescription of medicinal cannabis oil for patients with (a) cerebral palsy and (b) arthritis.
	tabling member constituency	Banff and Buchan
	tabling member printed	David Duguid
	uin	239283
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>The Department has not discussed with the National Institute for Health and Care Excellence (NICE) the prescription of medicinal cannabis oil for patients with cerebral palsy and arthritis.</p><p> </p><p>NICE is the independent expert body that develops authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources. NICE is developing guidance on the prescribing of cannabis-based medicinal products by October 2019. It will be based on the best available international evidence and will have been produced using NICE’s world-renowned process for delivering such guidance.</p><p> </p><p>Following a public consultation on the draft scope, the guidance will focus on the use of cannabis-based products in the treatment of chronic pain, intractable nausea and vomiting, spasticity and severe treatment-resistant epilepsy, conditions where the evidence is currently most advanced. A consultation on the draft guidance is expected in the summer.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:41:04 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4606 label Biography information for David Duguid

1108996

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Travellers and Homelessness
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps (a) his Department plans to take with the NHS to respond to the findings of the Friends Families and Travellers’ report entitled No room at the inn: How easy is it for nomadic Gypsies and Travellers to access primary care and (b) the NHS plans to take to ensure homeless people can access healthcare at any GP practice they choose.
	tabling member constituency	Bermondsey and Old Southwark
	tabling member printed	Neil Coyle
	uin	240011
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Registering with and access to primary medical care services is the same for all patients, whether they are gypsies, travellers, or homeless people. People do not need to provide proof of address to register with a general practice (GP). NHS England is working with a range of community groups to redesign the patient registration leaflet so that people are aware of this when registering. The free NHS 111 service can assist anyone who has faced difficulty finding a GP or accessing other services in their local area.</p><p> </p><p>NHS England is aware of difficulties some individuals have faced when trying to register with a GP and is taking steps to address shortcomings with individual practices, working in partnership with the voluntary sector.</p><p> </p><p>The Voluntary, Community and Social Enterprise Health and Wellbeing Alliance is a partnership arrangement with the aim to facilitate integrated working between the voluntary and statutory sectors, to promote equality and reduce health inequalities. It receives £1.2 million for core work from the Department, with each member receiving funding of up to £60,000. Families and Travellers is a member of the Alliance and have supported the Department on a range of work to date including the Inclusion Health Audit Tool, on maternal health, mental health, end of life care and dementia.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:33:43 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4368 label Biography information for Neil Coyle

1109014

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to increase access to Tier 3 obesity services.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	240051
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Public Health England has been working with NHS England to support approaches to obesity as part of the NHS Long Term Plan. The NHS Long Term Plan has a number of different actions to support the drive to reduce obesity, including investment in tier 3 services for both children and adults and plans are in development for this expansion. This will result in, for example, a further 1,000 children a year being treated by 2022/23 for severe complications related to obesity.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:35:00 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4532 label Biography information for Derek Thomas

1109018

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 27 March 2018 to Question 133501 on obesity, for what reason his Department does not hold information on the number of tier three obesity services commissioned by clinical commissioning groups or local authorities; and whether he plans to collate that information.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	240054
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>It would not be cost-effective for the Department to collect data on every clinical intervention, including information on tier three obesity services commissioned by clinical commissioning groups or local authorities.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:36:07 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4532 label Biography information for Derek Thomas

1109022

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sterilisation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many Clinical Commissioning Groups commission vasectomy services for patients who are not in exceptional circumstances.
	tabling member constituency	Oxford East
	tabling member printed	Anneliese Dodds
	uin	240100
	answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>This is a matter for local clinical commissioning groups, and the information requested is not held centrally by the Department or NHS England.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/04/2019 15:26:41 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4657 label Biography information for Anneliese Dodds

1109066

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatic Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the survival rate of patients with pancreatic cancer.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	239856
	answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>Later this year, the Government will begin the roll-out of new Rapid Diagnostic Centres across the country to upgrade and bring together the latest diagnostic equipment and expertise, which focus on diagnosing cancers where patients often present with non-specific symptoms, like pancreatic cancer, and may go to their general practitioner (GP) many times before being sent for tests.</p><p> </p><p>This is part of the NHS Long Term Plan that was published in January 2019. It sets a new ambition that, by 2028, the proportion of cancers diagnosed at stages 1 and 2 will rise from around half now to three-quarters of cancer patients. Achieving this will mean that, from 2028, 55,000 more people each year will survive their cancer for at least five years after diagnosis. We will build on work to raise greater awareness of symptoms of cancer, lower the threshold for referral by GPs, accelerate access to diagnosis and treatment and maximise the number of cancers that we identify through screening. This includes the use of personalised and risk stratified screening and beginning to test the family members of cancer patients where they are at increased risk of cancer.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/04/2019 15:28:26 answering member 4455 label Biography information for Seema Kennedy
	tabling member	308 label Biography information for Mr Jim Cunningham

1109073

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hyperkalaemia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the prevalence of hyperkalaemia for patients with chronic kidney disease.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	239857
	answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>Hyperkalaemia usually occurs in patients with renal impairment which can be acute or chronic. In patients with chronic kidney disease (CKD), several factors increase susceptibility to hyperkalaemia including a high dietary potassium intake relative to residual renal function. When patients with CKD have other risk factors, for example treatment with drugs that interfere with the renin-angiotensin-aldosterone system, the risk of hyperkalaemia is further increased. Clinical presentation of hyperkalaemia is highly variable with some patients presenting with an acute illness whilst others may be asymptomatic.</p><p> </p><p>Although not completely preventable, the risk of developing hyperkalaemia can be reduced. Clinical practice guidelines treatment of acute hyperkalaemia in adults, a collaboration between the Renal Association and Resuscitation Council UK that is endorsed by a range of organisations, including the College of Emergency Medicine and the Faculty of Intensive Care medicine, sets out evidence-based guidance on the management of the condition. It was developed to improve the treatment of acute hyperkalaemia and to reduce the risk of complications associated with hyperkalaemia and its treatment. The main measures in primary prevention in patients with CKD are regular blood monitoring, careful drug prescribing and dietary advice. Patient information and education may reduce the risk of inadvertent hyperkalaemia. The guidance can be found at the following link:</p><p> </p><p><a href="https://renal.org/wp-content/uploads/2017/06/hyperkalaemia-guideline-1.pdf" target="_blank">https://renal.org/wp-content/uploads/2017/06/hyperkalaemia-guideline-1.pdf</a></p><p> </p><p>Information regarding the annual cost to the National Health Service of treating hyperkalaemia in Coventry South and England is not available. This answer covers England only. Funding of such services in the other United Kingdom nations is a matter for the respective devolved administrations.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 239865 question first answered 08/04/2019 15:20:04 answering member 4455 label Biography information for Seema Kennedy
	tabling member	308 label Biography information for Mr Jim Cunningham

1109089

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of NHS prescription drugs are issued in recyclable packaging.
	tabling member constituency	Portsmouth South
	tabling member printed	Stephen Morgan
	uin	240096
	answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>The information requested is not held centrally.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/04/2019 15:27:29 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4653 label Biography information for Stephen Morgan

1109260

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hyperkalaemia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the annual cost to the NHS of treating hyperkalaemia in (a) Coventry South constituency and (b) the UK.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	239865
	answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>Hyperkalaemia usually occurs in patients with renal impairment which can be acute or chronic. In patients with chronic kidney disease (CKD), several factors increase susceptibility to hyperkalaemia including a high dietary potassium intake relative to residual renal function. When patients with CKD have other risk factors, for example treatment with drugs that interfere with the renin-angiotensin-aldosterone system, the risk of hyperkalaemia is further increased. Clinical presentation of hyperkalaemia is highly variable with some patients presenting with an acute illness whilst others may be asymptomatic.</p><p> </p><p>Although not completely preventable, the risk of developing hyperkalaemia can be reduced. Clinical practice guidelines treatment of acute hyperkalaemia in adults, a collaboration between the Renal Association and Resuscitation Council UK that is endorsed by a range of organisations, including the College of Emergency Medicine and the Faculty of Intensive Care medicine, sets out evidence-based guidance on the management of the condition. It was developed to improve the treatment of acute hyperkalaemia and to reduce the risk of complications associated with hyperkalaemia and its treatment. The main measures in primary prevention in patients with CKD are regular blood monitoring, careful drug prescribing and dietary advice. Patient information and education may reduce the risk of inadvertent hyperkalaemia. The guidance can be found at the following link:</p><p> </p><p><a href="https://renal.org/wp-content/uploads/2017/06/hyperkalaemia-guideline-1.pdf" target="_blank">https://renal.org/wp-content/uploads/2017/06/hyperkalaemia-guideline-1.pdf</a></p><p> </p><p>Information regarding the annual cost to the National Health Service of treating hyperkalaemia in Coventry South and England is not available. This answer covers England only. Funding of such services in the other United Kingdom nations is a matter for the respective devolved administrations.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 239857 question first answered 08/04/2019 15:20:04 answering member 4455 label Biography information for Seema Kennedy
	tabling member	308 label Biography information for Mr Jim Cunningham

1109266

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity: Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle the rate of cancer caused by obesity.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	239986
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>We published the second chapter of our world-leading childhood obesity plan in June 2018. This builds on the real progress we have made since the publication of chapter one in 2016, particularly in reformulation of the products our children eat and drink most. In chapter two we have set a bold ambition to halve childhood obesity by 2030 and significantly reduce the gap in obesity between children from the most and least deprived areas by 2030.</p><p> </p><p>Many of the measures in both chapters of the plan will have an impact on tackling obesity across all age groups. These include the soft drinks industry levy, sugar reduction and wider calorie reformulation programme, restricting promotions and calorie labelling in restaurants which will improve our eating habits and reduce the amount of sugar we consume.</p><p> </p><p>‘Childhood obesity: a plan for action, chapter 2’ is available at the following link:</p><p> </p><p><a href="http://www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2" target="_blank">www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:37:48 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4131 label Biography information for Jim Shannon